Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Filgrastim-sndz (Zarxio) is the first biosimilar product approved in the United States. It has been determined to be biosimilar to filgrastim (Neupogen).